Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DYSTONIA
Document Type and Number:
WIPO Patent Application WO/2019/107767
Kind Code:
A1
Abstract:
The present invention relates to a novel pharmaceutical composition for the treatment of dystonia or the relief of pain caused by muscle tension and provides a pharmaceutical composition comprising a serotonin receptor 5-HT2A inhibitor as an effective ingredient for treating dystonia or relieving pain caused by muscle tension.

Inventors:
KIM, Dae Soo (291 Daehak-ro, Yuseong-gu, Daejeon, 34141, KR)
KIM, Jung Eun (291 Daehak-ro, Yuseong-gu, Daejeon, 34141, KR)
Application Number:
KR2018/013159
Publication Date:
June 06, 2019
Filing Date:
November 01, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (291 Daehak-ro, Yuseong-gu, Daejeon, 34141, KR)
International Classes:
A61K31/5513; A61K31/15; A61K31/5517; G01N33/50; G01N33/94
Foreign References:
KR20050094857A2005-09-28
US20150231126A12015-08-20
US20110190345A12011-08-04
Other References:
KATO, KOJI ET AL.: "Case of Tardive Dystonia Improved by Aripiprazole", PSYCHIATRY AND CLINICAL NEUROSCIENCES, vol. 64, no. 3, 18 May 2010 (2010-05-18) - June 2010 (2010-06-01), pages 336 - 339, XP055615547
KIM, J. ET AL.: "Serotonin Mediates Stress Induced Dystonia through 5HT2A Receptor in Tottering Mice", SOCIETY FOR NEUROSCIENCE, NEUROSCIENCE 2017 ABSTRACTS, 12 November 2017 (2017-11-12)
Attorney, Agent or Firm:
HAN, Yun Ho (YULMIN IP LAW FIRM, Nice Building 2nd Floor, 28 Saimdang-ro,Seocho-gu, Seoul, 06651, KR)
Download PDF: